| Wang, Hong |
NCT03895411: Efficacy and Safety of Sotalol in Children With Arrhythmia |
|
|
| Not yet recruiting | 4 | 500 | RoW | sotalol, Propafenone, betaloc | Shengjing Hospital | Arrhythmia | 12/20 | 12/22 | | |
NCT04766307: A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2 |
|
|
| Recruiting | 4 | 1100 | RoW | Interleukin-2, IL-2 | Beijing Chest Hospital | Tuberculosis, Pulmonary | 12/21 | 12/21 | | |
| Active, not recruiting | 3 | 466 | Europe, Canada, Japan, US, RoW | tucatinib, ONT-380, placebo, T-DM1, Kadcyla | Seagen Inc., Seagen Inc., Seattle Genetics, Inc., Seagen Inc | HER2-positive Breast Cancer | 06/23 | 10/27 | | |
|
|
EMBER-3, NCT04975308 / 2021-000079-35: A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer |
|
|
| Active, not recruiting | 3 | 866 | Europe, Japan, US, RoW | Imlunestrant, LY3484356, Exemestane, Fulvestrant, Abemaciclib, LY2835219 | Eli Lilly and Company, Eli Lilly and Company | Breast Neoplasms, Neoplasm Metastasis | 06/24 | 08/27 | | |
| Completed | 3 | 257 | RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Diabetes Type 2, Diabetes Mellitus, Glucose Metabolism Disorders, Metabolic Disease, Endocrine System Diseases | 07/24 | 07/24 | | |
| Active, not recruiting | 3 | 654 | Europe, Canada, Japan, US, RoW | Tucatinib, TUKYSA, ONT-380, ARRY-380, Trastuzumab, Herceptin, Herceptin Hylecta, Pertuzumab, Perjeta, Combination product: Trastuzumab + Pertuzumab, Phesgo, Placebo | Seagen Inc., Merck Sharp & Dohme LLC | HER2 Positive Breast Cancer | 05/25 | 10/27 | | |
|
ATTAIN-1, NCT05869903: A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities |
|
|
| Active, not recruiting | 3 | 3000 | Europe, Japan, US, RoW | Orforglipron, LY3502970, Placebo | Eli Lilly and Company | Obesity, Overweight, Overweight or Obesity | 07/25 | 07/27 | | |
NCT05520177: A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss |
|
|
| Recruiting | 3 | 350 | RoW | 601 1.25mg, 601, ranibizumab 0.5mg, Lucentis | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Branch Retinal Vein Occlusion | 12/25 | 12/25 | | |
| Active, not recruiting | 3 | 15374 | Europe, Canada, Japan, US, RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Obesity, Overweight | 10/27 | 10/27 | | |
NCT04398940: A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer |
|
|
| Recruiting | 2 | 71 | RoW | TQ-B3139 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Non Small Cell Lung Cancer | 01/22 | 10/22 | | |
NCT06196840: Safety and Efficacy of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (VENUS) |
|
|
| Recruiting | 2 | 50 | RoW | LX102 subretinal injection, Aflibercept intravitreal injection | Innostellar Biotherapeutics Co.,Ltd | Neovascular Age-Related Macular Degeneration | 05/25 | 05/29 | | |
| Recruiting | 2 | 168 | RoW | Propranolol Hydrochloride, control group | Beijing Tiantan Hospital | Stroke, Vascular Accident, Intracranial Hemorrhages, Intracerebral Hemorrhage, Hemorrhagic Stroke, Stroke, Acute | 07/24 | 07/25 | | |
NCT06212297: Fellow-eye Study (FE) of LX101 in Subjects With Inherited Retinal Dystrophy |
|
|
| Recruiting | 1/2 | 9 | RoW | LX101 | Innostellar Biotherapeutics Co.,Ltd | Inherited Retinal Dystrophy | 09/24 | 03/29 | | |
NCT04458389: A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas |
|
|
| Recruiting | 1/2 | 268 | RoW | TY101 | Tayu Huaxia Biotech Medical Group Co., Ltd. | Locally Advanced /Metastatic Solid Tumors, Relapsed or Refractory Lymphomas | 06/24 | 07/25 | | |
NCT06198413: LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD) |
|
|
| Recruiting | 1 | 12 | RoW | LX102 subretinal injection | Innostellar Biotherapeutics Co.,Ltd | Neovascular Age-Related Macular Degeneration | 01/25 | 01/29 | | |
| Completed | 1 | 46 | RoW | CM326, Placebo | Keymed Biosciences Co.Ltd | Healthy | 10/23 | 10/23 | | |
| Recruiting | 1 | 40 | RoW | ZL-82, 600mg ZL-82, 50mg ZL-82, 100mg ZL-82, 200mg ZL-82, ZL-82 placebo, 600mg ZL-82 placebo, 50mg ZL-82 placebo, 100mg ZL-82 placebo, 200mg ZL-82 placebo | Chengdu Zenitar Biomedical Technology Co., Ltd | Healthy Person | 08/24 | 12/24 | | |
NCT05702450: Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310 |
|
|
| Completed | 1 | 240 | RoW | CM310 | Keymed Biosciences Co.Ltd | Healthy | 07/23 | 07/23 | | |
NCT01360606: Stereotactic Body Radiation Therapy (SBRT) for Liver Mets |
|
|
| Completed | N/A | 9 | US | Stereotactic Body Radiation Therapy, CyberKnife, Trilogy, True Beam, Radiosurgery | Susannah Ellsworth | Liver Metastases | 07/18 | 02/21 | | |
NCT03839654: Loop Gain in the Reversion of OSA Treated by Either CPAP or Cardiac Valve Replacement |
|
|
| Recruiting | N/A | 40 | RoW | continuous positive airway pressure | Nanjing Medical University | Obstructive Sleep Apnea of Adult, Heart Valve Diseases | 06/23 | 12/23 | | |
| Active, not recruiting | N/A | 200 | RoW | Shockwave Coronary Intravascular Lithotripsy (IVL) catheter | First Affiliated Hospital of Guangxi Medical University | Coronary Artery Disease, Calcification | 08/24 | 12/25 | | |
DISCO, NCT06507488: Daphnetin Capsule In the Treatment of VaScular COgnitive Impairment Without Dementia |
|
|
| Not yet recruiting | N/A | 206 | RoW | Daphnetin Capsule, 7,8-dihydroxycoumarin, Placebo | First People's Hospital of Shenyang | Cerebrovascular Disorders | 12/25 | 04/26 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
NCT04638959: Study of Faecal Bacteria Detection in Early Screening and Diagnosis of GC |
|
|
| Recruiting | N/A | 1100 | RoW | collect gastric tissue and stool samples | Shanghai Jiao Tong University School of Medicine, Shanghai Changzheng Hospital, Ruijin Hospital, Jing'an District Central Hospital of Shanghai, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, Nanfang Hospital of Southern Medical University, the Seventh Medical Center of PLA General Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Zhongshan Hospital Xiamen University, Tianjin Medical University General Hospital | Non-invasive and Sensitive Faecal Bacterial Markers for Early Screening and Diagnosis of Gastric Cancer | 03/21 | 09/21 | | |
NCT05515549: Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients |
|
|
| Not yet recruiting | N/A | 300 | RoW | Venous blood was collected from patients under fasting state to detect the level of thrombus molecular markers | Qianfoshan Hospital | Venous Thromboembolic Disease | 12/24 | 12/24 | | |
